Brain-to-vein and vein-to-vein times and outcomes in CAR T-cell therapy in myeloma. - Grischke TK; Cooperrider JH; Pula A; Sneider A; Yates S; Jakubowiak AJ; Derman BA (Blood cancer journal, 2025)